Matthew E. Monaghan's most recent trade in Syneos Health Inc - Ordinary Shares - Class A was a trade of 4,863 Class A Common Stock done . Disclosure was reported to the exchange on May 25, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Syneos Health Inc - Ordina... | Matthew E. Monaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 4,863 | 24,640 (0%) | 0% | 0 | Class A Common Stock | |
Syneos Health Inc - Ordina... | Matthew E. Monaghan | Director | Sale of securities on an exchange or to another person at price $ 74.35 per share. | 31 May 2022 | 200 | 19,777 (0%) | 0% | 74.4 | 14,870 | Class A Common Stock |
Syneos Health Inc - Ordina... | Matthew E. Monaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 2,839 | 19,977 (0%) | 0% | 0 | Class A Common Stock | |
Syneos Health Inc - Ordina... | Matthew E. Monaghan | Director | Sale of securities on an exchange or to another person at price $ 88.64 per share. | 16 Jul 2021 | 170 | 17,138 (0%) | 0% | 88.6 | 15,069 | Class A Common Stock |
Syneos Health Inc - Ordina... | Matthew E. Monaghan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 2,364 | 17,308 (0%) | 0% | 0 | Class A Common Stock | |
Syneos Health Inc - Ordina... | Matthew E. Monaghan | Director | Grant, award, or other acquisition of securities at price $ 62.43 per share. | 27 May 2020 | 2,803 | 14,944 (0%) | 0% | 62.4 | 174,991 | Class A Common Stock |